publication date: Jul. 2, 2015
20150702 - Jul. 2, 2015
ISSUE 26 – JULY 3, 2015PDF

How NCI Will Spend New Money (If it Comes)

 

Is new money on the way to NCI? It’s certainly been promised in President Obama’s budget proposal and in the appropriations bills gestating in the House and Senate.

Those who seek logic in history will read much into timing:

After a decade of flat funding, decreases and inflationary erosion, the purchasing power of the NIH budget is where it was the year the doubling began in 1999.

Yet, a cycle this is not. The institute’s 1999 message was “Give us the money and we will use it wisely, because we are the best.”
In 2015, a leaner, more focused NCI is delivering the more compelling message: “Give us the money and we will give you the cutting edge of precision medicine.”

 

Lowy’s First Director’s Report to Advisory Panel

The following is a transcript of NCI Acting Director Douglas Lowy’s remarks to the joint meeting of the National Cancer Advisory Board and the NCI Board of Scientific Advisors, June 24:

I’m coming to the close of my third month as acting director, and I’d like to give you a status report. It has been really interesting and exciting for me and I can’t thank all of you enough for your incredible support—both my colleagues in NCI, and so many of you extramural colleagues.

    Senate Appropriators Approve $2 Billion for NIH

    The Senate Committee on Appropriations June 25 approved the fiscal 2016 Labor, Health and Human Services, and Education Appropriations Bill, which would boost NIH’s budget to $32 billion—an increase of $2 billion above fiscal 2015.

    The $153.2 billion measure would provide the largest increase NIH has received since the doubling of its budget was completed in 2003.

    BSA Approves Three Concepts at Joint Meeting with NCAB

    The NCI Board of Scientific Advisors approved the following concepts at a meeting June 24:

    • The Non-Communicable Disease Regional Infrastructure Core Planning Grants program seeks to support activities for the planning and designing of sustainable, regional research infrastructure core, established to build, strengthen, and coordinate research and training of non-communicable diseases in low and middle-income countries or regions.

      The Cancer Letter’s Coverage of Power Morcellation Wins Three Journalism Awards

      The Cancer Letter won a first place 2015 National Press Club Award in the NPC’s annual journalism competition June 26.

      The award recognizes Matthew Ong’s series “Power Morcellation: A Hazardous Practice” as the winner in the Newsletter Journalism category.

        In Brief

        • Raphael Pollock named surgeon-in-chief for OSU Health System

        • Jonathan Licht named director of UF Cancer Center

        • George Wilding named vice provost at MD Anderson Cancer Center 

        • LIVESTRONG Foundation appoints Donna Palmer and Katie Merrell to leadership team

        • Cyrus Ghajar receives $4.1 million award from the Department of Defense

        Drugs and Targets

        • EMA grants accelerated approval to Opdivo in metastatic melanoma

        • Leukemia & Lymphoma Society accelerates payment to Celator Pharmaceuticals

        • Mevion Medical Systems delivers proton accelerator to UH Seidman Cancer Center
        • Proton Partners International Ltd. acquires site for proton beam therapy center in Wales

        Copyright (c) 2020 The Cancer Letter Inc.